NO980127L - Use of ipriflavone to reduce the number of CD8 + cells - Google Patents
Use of ipriflavone to reduce the number of CD8 + cellsInfo
- Publication number
- NO980127L NO980127L NO980127A NO980127A NO980127L NO 980127 L NO980127 L NO 980127L NO 980127 A NO980127 A NO 980127A NO 980127 A NO980127 A NO 980127A NO 980127 L NO980127 L NO 980127L
- Authority
- NO
- Norway
- Prior art keywords
- cells
- ipriflavone
- reduce
- isopropoxyisoflavone
- lymphocytes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Abstract
Farmasøytiske preparater egnet for å redusere antall CD8+ celler bestående av 7-isopropoksyisoflavon som aktiv ingrediens i en blanding med egnet inert, fast eller flytende bærere og eventuelt med vanlig terapeutiske additiver og hjelpestoffer. Det farmasøytiske preparatet fremstilles ved kjente metoder og er egnet for behandling av mennesker og dyr som er i en tilstand der selektiv suppresjon av CD8+ lymfocytter er hensiktsmessig.Pharmaceutical preparations suitable for reducing the number of CD8 + cells consisting of 7-isopropoxyisoflavone as active ingredient in a mixture of suitable inert, solid or liquid carriers and optionally with usual therapeutic additives and excipients. The pharmaceutical composition is prepared by known methods and is suitable for treating humans and animals in a state where selective suppression of CD8 + lymphocytes is appropriate.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9502198A HU9502198D0 (en) | 1995-07-21 | 1995-07-21 | Novel indication |
| PCT/HU1996/000038 WO1997003664A1 (en) | 1995-07-21 | 1996-07-16 | Use of ipriflavone to reduce the number of cd8+ cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO980127D0 NO980127D0 (en) | 1998-01-12 |
| NO980127L true NO980127L (en) | 1998-01-12 |
Family
ID=10987063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO980127A NO980127L (en) | 1995-07-21 | 1998-01-12 | Use of ipriflavone to reduce the number of CD8 + cells |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0841915A1 (en) |
| JP (1) | JP2001503371A (en) |
| KR (1) | KR19990028933A (en) |
| CN (1) | CN1191483A (en) |
| AR (1) | AR002905A1 (en) |
| AU (1) | AU6367096A (en) |
| BG (1) | BG102182A (en) |
| BR (1) | BR9610187A (en) |
| CA (1) | CA2227421A1 (en) |
| CZ (1) | CZ2798A3 (en) |
| EA (1) | EA199800146A1 (en) |
| EE (1) | EE9800020A (en) |
| HR (1) | HRP960345A2 (en) |
| HU (1) | HU9502198D0 (en) |
| IL (1) | IL122751A0 (en) |
| MX (1) | MX9800603A (en) |
| NO (1) | NO980127L (en) |
| PL (1) | PL324460A1 (en) |
| SK (1) | SK3298A3 (en) |
| WO (1) | WO1997003664A1 (en) |
| YU (1) | YU42796A (en) |
| ZA (1) | ZA966079B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1241079B (en) * | 1990-03-23 | 1993-12-29 | Chiesi Farma Spa | PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE |
| HU212932B (en) * | 1993-08-02 | 1996-12-30 | Chinoin Gyogyszer Es Vegyeszet | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
-
1995
- 1995-07-21 HU HU9502198A patent/HU9502198D0/en unknown
-
1996
- 1996-07-16 WO PCT/HU1996/000038 patent/WO1997003664A1/en not_active Application Discontinuation
- 1996-07-16 JP JP50646497A patent/JP2001503371A/en active Pending
- 1996-07-16 CN CN96195722A patent/CN1191483A/en active Pending
- 1996-07-16 SK SK32-98A patent/SK3298A3/en unknown
- 1996-07-16 AU AU63670/96A patent/AU6367096A/en not_active Abandoned
- 1996-07-16 EP EP96923004A patent/EP0841915A1/en not_active Withdrawn
- 1996-07-16 KR KR1019980700235A patent/KR19990028933A/en not_active Application Discontinuation
- 1996-07-16 EE EE9800020A patent/EE9800020A/en unknown
- 1996-07-16 CZ CZ9827A patent/CZ2798A3/en unknown
- 1996-07-16 PL PL96324460A patent/PL324460A1/en unknown
- 1996-07-16 BR BR9610187A patent/BR9610187A/en not_active Application Discontinuation
- 1996-07-16 EA EA199800146A patent/EA199800146A1/en unknown
- 1996-07-16 IL IL12275196A patent/IL122751A0/en unknown
- 1996-07-16 CA CA002227421A patent/CA2227421A1/en not_active Abandoned
- 1996-07-16 MX MX9800603A patent/MX9800603A/en unknown
- 1996-07-17 ZA ZA9606079A patent/ZA966079B/en unknown
- 1996-07-18 HR HRP9502198A patent/HRP960345A2/en not_active Application Discontinuation
- 1996-07-19 YU YU42796A patent/YU42796A/en unknown
- 1996-07-22 AR ARP960103677A patent/AR002905A1/en unknown
-
1998
- 1998-01-12 NO NO980127A patent/NO980127L/en unknown
- 1998-01-14 BG BG102182A patent/BG102182A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9800603A (en) | 1998-04-30 |
| BG102182A (en) | 1998-08-31 |
| NO980127D0 (en) | 1998-01-12 |
| PL324460A1 (en) | 1998-05-25 |
| EP0841915A1 (en) | 1998-05-20 |
| WO1997003664A1 (en) | 1997-02-06 |
| ZA966079B (en) | 1998-01-19 |
| EA199800146A1 (en) | 1998-08-27 |
| CZ2798A3 (en) | 1998-06-17 |
| YU42796A (en) | 1999-03-04 |
| HRP960345A2 (en) | 1998-02-28 |
| EE9800020A (en) | 1998-08-17 |
| JP2001503371A (en) | 2001-03-13 |
| BR9610187A (en) | 1998-07-28 |
| AR002905A1 (en) | 1998-04-29 |
| KR19990028933A (en) | 1999-04-15 |
| WO1997003664A8 (en) | 1999-08-05 |
| CN1191483A (en) | 1998-08-26 |
| IL122751A0 (en) | 1998-08-16 |
| CA2227421A1 (en) | 1997-02-06 |
| AU6367096A (en) | 1997-02-18 |
| SK3298A3 (en) | 1998-07-08 |
| HU9502198D0 (en) | 1995-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO854211L (en) | PHARMACEUTICAL MIXTURE AND PROCEDURE FOR TREATING THE BODY. | |
| HK1007102A1 (en) | Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma | |
| SE8702907D0 (en) | STABLE PHARMACEUTICAL PREPARATION CONTAINING GRANULOCYTE COLONY STIMULATING FACTOR AND PROCESS FOR PRODUCING THE SAME | |
| SE9704870D0 (en) | New pharmaceutical formulation I | |
| GEP20033131B (en) | Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity | |
| MX9307509A (en) | Method and pharmaceutical preparation to reduce cell activity. | |
| ATE215827T1 (en) | IMMUNOLOGICAL ACTIVITY OF RHAMNOLIPIDS | |
| RU94044436A (en) | Method of suppression of skin and vagina atrophy | |
| CA2015838A1 (en) | Method of topically treating acne vulgaris | |
| DK0957906T3 (en) | Local anesthetic for topical use | |
| ES8100883A1 (en) | Transdermal medication system for isosorbide dinitrate | |
| NO994640L (en) | Cough relievers | |
| ATE15596T1 (en) | PHARMACEUTICAL AGENT. | |
| ES2108129T3 (en) | NEW DERIVATIVES OF PIRAZINE, ITS PREPARATION AND USE. | |
| NO996049L (en) | Controlled release pharmaceutical preparation, with ACE inhibitor as active ingredient | |
| JO1589B1 (en) | Antiviral tetrahydroimidazo(1,4)benzodiazepin-2-ones | |
| BG60101B2 (en) | Method for preparing of 4-fluoro-2-[[(4-methoxy-2-pyridinyl)methyl]thionil]-1h-benzimidazo le | |
| NO980127L (en) | Use of ipriflavone to reduce the number of CD8 + cells | |
| AU574534B2 (en) | Anticoccidial compositions | |
| NO950950L (en) | Pharmaceutical preparation | |
| NO20001846L (en) | New pharmaceutically active compounds, their preparation and use as ECE inhibitors | |
| NO932097L (en) | Soft pharmaceutical capsules containing lysine clonixinate and methods for their preparation | |
| CO4750838A1 (en) | METHOD FOR THE TREATMENT OF ADVERSE INFLAMMATORY REACTIONS AND ADMINISTERED ANTI-INFLAMMATORY COMPOSITION | |
| DK0654042T3 (en) | Amylin muteins | |
| CA2153570A1 (en) | Pharmaceutical composition for treating nicotine dependence |